Cardiorenal Syndrome in Patients with Chronic Kidney Disease and Ischemic Heart Disease

A.N. Korzh

Abstract


.

References


McCullough P.A., Haapio M., Mankad S. et al. Prevention of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference // Nephrol. Dial. Transplant. — 2010. — 25. — 1777-1784.

McAlister F.A., Stewart S., Ferrua S., McMurray J.J. Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials // J. Am. Coll. Cardiol. — 2004. — 44. — 810-819.

Bagshaw S.M., Cruz D.N., Aspromonte N. et al. Epidemio­logy of cardio-renal renal syndromes: workgroup statements from the 7th ADQI Consensus Conference // Nephrol. Dial. Transplant. — 2010. — 25. — 1406-1416.

Davenport A., Cox C., Thuraisingham R. The importance of dialysate sodium concentration in determining interdialytic weight gains in chronic hemodialysis patients: the Pan Thames Renal Audit // Int. J. Artif. Organs. — 2008. — 31. — 411-417.

Selby N.M., McIntyre C.W. The acute cardiac affects of dialysis // Semin. Dial. — 2007. — 20. — 220-228.

Ronco C., Haapio M., House A. et al. Cardiorenal syndrome // JACC. — 2008. — 52 (19). — 1527-1539.

Мухин Н.А., Моисеев В.С. Кардиоренальные соотношения и риск сердечно-сосудистых заболеваний // Вестник РАМН. — 2003. — 11. — 50-55.

Березинец О.Л. Современные аспекты развития и прогрессирования ишемической болезни сердца у больных хронической болезнью почек (обзор) / О.Л. Березинец, А.Н. Россоловский, Б.И. Блюмберг // Бюллетень медицинских интернет-конференций. — 2014. — Т. 4, № 1. — С. 72-75.

Бова А.А. Хроническая болезнь почек как независимый фактор риска сердечно-сосудистой патологии // Военная медицина. — 2014. — № 2. — С. 15-21.

Ronco C., McCullough P.A., Anker S.D. et al. Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative // European Heart Journal. — 2010. — 31. — 703-711.

McCullough P.A., Wolyn R., Rocher L.L. et al. Acute renal failure after coronary intervention: incidence, risk factors, relationship to mortality // Am. J. Med. — 1997. — 103. — 368-375.

Исследование альбуминурии как маркера хронической болезни почек у взрослого трудоспособного населения / С.С. Нагайцева, М.Ю. Швецов, А.Н. Герасимов [и др.] // Альманах клинической медицины. — 2014. — № 30. — С. 37-45.

Daveport A., Anker S.D., Mebazaa A. et al. ADQI 7: the clinical management of cardio-renal syndromes: workgroup statements from the 7th ADQI consensus conference // Nephrol. Dial. Transplant. — 2010. — 25. — 2077-2089.

Артериальная жесткость и хроническая болезнь почек: причины и последствия / Ж.Д. Кобалава, Ю.В. Котовская, С.В. Виллевальде [и др.] // Рациональная фармакотерапия в кардиологии. — 2014. — Т. 10, № 1. — С. 83-91.

Wasse H., Gillen D.L., Ball A.M. at al. Risk factors for upper gastrointenstinal bleeding among end-stage renal disease patients // Kidney Int. — 2003. — 64. — 1455-1461.

Elliott M.J., Zimmerman D., Holden R.M. Warfarin anticoagulation in hemodialysis patients: a systematic review of ble­eding rates // Am. J. Kidney Dis. — 2007. — 50. — 433-440.

Drueke T.B., Locatelli F., Clyne N. et al. Normalization of hemoglobin level in patientswith chronic kidney disease and anemia // N. Eng. J. Med. — 2006. — 355. — 2071-2084.

Foley R.N., Parfrey P.S., Morgan J. et al. Effect of hemoglobin level in hemodialysispatients with asymptomatic cardiomyopathy // Kidney Int. — 2000. — 58. — 1325-1335.

Gilbertson D., Li. S., Murray A.M. et al. Competing risks of death vs ESRD in Medicarebeneficiaries age 65? with chronic kidney disease CHF and anemia // J. Am. Soc. Nephrol. — 2002. — 13. — SA848.

Greaves S.C., Gamble G.D., Collins J.F. et al. Determinants of left ventricularhyperthrophy and systolic dysfunction in chronic renal failure // Am. J. Kidney Dis. — 1994. — 24. — 768-776.

Hampl H., Hennig L., Rosenberger C. et al. Effects of optimised heart failure therapy andanemia correction with epoetin beta on left ventricular mass in hemodialysis patients // Am. J. Nephrol. — 2005. — 25. — 211-220.

Hayashi T., Suzuki A., Shoji T. et al. Cardiovascular effect of normalizing the hematocritlevel during erythropoetin therapy in predialysis patients with chronic renal failure // Am. J. Kidney Dis. — 2000. — 35. — 250-256.

Jin B., Luo X., Lin H. et al. A meta-analysis of erythropoiesis-stimulating agents inanaemic patients with chronic heart fai­lure // Eur. J. Heart Fail. — 2010. — 12. — 249-253.

Keane W.F., Brenner B.M., De Zeeuw D. et al. The risk of developing end-stage renaldisease in patients with type 2 diabetes and nephropathy: The RENAAL Study // Kidney Int. — 2003. — 63. — 1499-1507.

28. Khan S., Xue J., Kazmi W. et al. Does predialysis nephrology care influence patientsurvival after initiation of dialysis? // Kidney Int. — 2005. — 67. — 1038-1046.

ESH/ESC Guidelines for the management ofarterial hypertension // Eur. Heart J. — 2013. — doi: 10.1093/eurheartj/eht151.

Шутов А.М. Хроническая болезнь почек — глобальная проблема XXI века // Клиническая медицина. — 2014. — Т. 92, № 5. — С. 5-10.

Тонелли М. Хроническая болезнь почек и старение популяции / М. Тонелли, М. Риелла // Клиническая нефрология. — 2014. — № 1. — С. 4-7.

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) // Eur. Heart J. — 2012. — 33. — 1635-701.

Abd El-Aziz A. El-Kakand, EmanWagdy Effect of Erythropoietin Therapy on CardiacStructural and Functional Changes in End Stage Renal Disease. A Comparative Study of Full versus Partial Anemia Correction // Journal of the Medical Research Institute, JMRI. — 2008. — Vol. 29, 2. — 170-6.

Drueke T.B., Locatelli F., Clyne N. et al. Normalization of hemoglobin level in patientswith chronic kidney disease and anemia // N. Eng. J. Med. — 2006. — 355. — 2071-2084.

Levin A. Understanding recent hemoglobin trials in CKD: methods and lessons learnedfrom CREATE and CHOIR // Nephrol. Dial. Transplant. — 2007. — 22. — 309-312.

Kim E. Jie, Karien van der Putten, Marloes W.T. Bergevoet. Short- and long-term effectsof erythropoietin treatment on endothelial progenitor cell levels in patients withcardiorenal syndrome // Heart. — 2011 January. — 97 (1). — 60-65. Published online 2010 November 11. doi: 10.1136/hrt.2010.

Kim E. Jie, Zaikova M.A., Bergevoet M.W. et al. Progenitor cells and vascular function areimpaired in patients with chronic kidney disease // Nephrol. Dial. Transplant. — 2010. — 25. — 1875-82.




DOI: https://doi.org/10.22141/2307-1257.0.1.11.2015.75397

Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 KIDNEYS

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© "Publishing House "Zaslavsky", 1997-2017

 

 Яндекс.МетрикаSeo анализ сайта Рейтинг@Mail.ru